Company Filing History:
Years Active: 2018-2023
Title: Innovations by James Kyle Zorn
Introduction
James Kyle Zorn is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of pharmaceuticals, particularly in drug compositions aimed at treating gastrointestinal conditions. With a total of four patents to his name, Zorn's work reflects a commitment to advancing medical treatments.
Latest Patents
Zorn's latest patents include innovative pharmaceutical compositions that incorporate omeprazole and a benzimidazole drug. These compositions are designed for oral administration and are intended to treat various gastrointestinal conditions. Another patent focuses on compositions that combine a proton pump inhibitor with an antiparasitic drug, also formulated for oral administration. Both patents describe methods of treatment using these compositions, showcasing Zorn's dedication to improving patient care.
Career Highlights
Throughout his career, Zorn has been associated with Adamis Pharmaceuticals Corporation, where he has played a crucial role in developing new drug formulations. His expertise in pharmaceutical sciences has contributed to the company's mission of providing effective treatments for patients.
Collaborations
Zorn has collaborated with esteemed colleagues such as David Clayton Sutherland and Dennis J Carlo. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
James Kyle Zorn's contributions to pharmaceutical innovations highlight his expertise and commitment to improving healthcare. His patents reflect a significant advancement in the treatment of gastrointestinal conditions, underscoring the importance of his work in the medical field.